share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director RAPP EDWARD J

SEC announcement ·  May 8 06:36
Summary by Futu AI
Edward J. Rapp, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock on May 3, 2024. The transaction was completed at no cost to the recipient, as per the transaction code 'A', which indicates a grant, award, or other acquisition. Following this transaction, Rapp's direct holdings in AbbVie common stock increased to 31,356 shares. Additionally, it was reported that an indirect holding of 10,388 shares is owned by Rapp's spouse in trust. The total number of shares now beneficially owned by Rapp, both directly and indirectly, amounts to 41,744.
Edward J. Rapp, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock on May 3, 2024. The transaction was completed at no cost to the recipient, as per the transaction code 'A', which indicates a grant, award, or other acquisition. Following this transaction, Rapp's direct holdings in AbbVie common stock increased to 31,356 shares. Additionally, it was reported that an indirect holding of 10,388 shares is owned by Rapp's spouse in trust. The total number of shares now beneficially owned by Rapp, both directly and indirectly, amounts to 41,744.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.